Blood cancers, such as leukemia, lymphoma, myeloma, and several others, affect close to 200,000 people in the United States. Small differences in our genes are known to play a role in the development of many blood cancers. Several specific genes have been identified so far, but there is still much more to learn in order to develop new and better treatments.
Researchers at Rutgers University are recruiting 50,000 participants for a study exploring the role of genetic differences, called variants, in the risk of blood cancer. No office visit is required. Instead, there’s an easily accessible set of questions to answer (that will take about 15 minutes), combined with returning a “spit kit” that will be mailed to participants. Participants will not be compensated, but may opt to receive a report about their genetic ancestry at no cost. Participants may opt to fill in additional surveys, and to make parts of their electronic medical records available to enhance the study’s data.
We are looking for people who have had blood cancer and people who have not.
Findings from this study may lead to improved and personalized diagnostics and treatment.
Sign Up Here
F.A.Q. (Frequently Asked Questions)
Right-click and save or print this flyer: Study Flyer